TLC
Taiwan Liposome Company, Ltd. [TLC] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TLC Stock Summary
In the News
TLC Financial details
Company Rating
-
Market Cap
0
Income
-803.16M
Revenue
275.97M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
27 Oct 2021
P/E
-8.75
Forward P/E
-
PEG
3.88
P/S
-
P/B
19.65
P/C
-
P/FCF
-
Quick Ratio
3.96
Current Ratio
4.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-19.09
EPS next Y
-
EPS next Q
-
EPS this Y
1.01%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.52%
Revenue last 5Y
19.59%
Revenue Q/Q
325.8%
EPS Q/Q
-62.55%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-56%
ROE
-170%
ROC
-0.7%
Gross Margin
-
Oper. Margin
-965%
Profit Margin
-965%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7-7.09
52W High
0%
52W Low
0%
RSI
-
Rel Volume
0.71
Avg Volume
17.61K
Volume
12.42K
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
0%
-
-
-
-
Beta
0.797218
-
-
Volatility
0%, 0%
Prev Close
0%
Price
7
Change
0%
Company Profile
- Volume Average 17.61K
- CEO Dr. Keelung Hong
- Headquarters Taipei,TW
- IPO Date 2018-11-21
-
Website
http://www.tlcbio.com 
